Organization Overview
Historical Acquisition Tree
Alternative names
Key: Daiichi Sankyo (6) Acquired (5)
edoxaban (savaysa) (2015 NDA)
fam-trastuzumab deruxtecan-nxki (Enhertu) (2019 NDA)
pexidartinib (Turallo) (2019 NDA)
prasugrel (effient) (2009)
Key: Daiichi Sankyo (29) Acquired (7)
acetylsalicylic acid (aspirin) (12 trials)
amlodipine (norvasc) (15 trials)
atenolol (tenormin) (4 trials)
atorvastatin (lipitor) (2 trials)
benazepril (lotensin) (1 trial)
cholestyramine (questran) (2 trials)
clopidogrel (plavix) (26 trials)
edoxaban (savaysa) (36 trials)
everolimus (zortress) (1 trial)
fenofibrate (fenoglide) (1 trial)
ferric carboxymaltose (Injectafer) (28 trials)
hydralazine (apresoline) (1 trial)
Key: Daiichi Sankyo (52) Acquired (14)
aminohydroxybutane bisphosphonate (1 trial)
candesartan (atacand) (1 trial)
capecitabine (xeloda) (8 trials)
carboplatin (paraplatin) (11 trials)
cevimeline hydrochloride (evoxac) (1 trial)
cisplatin (platinol) (6 trials)
colchicine (colbenemid) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (9 trials)
daunorubicin (cerubidine) (3 trials)
docetaxel (taxotere) (2 trials)
enoxaparin (lovenox) (7 trials)
erlotinib (tarceva) (5 trials)
etanercept (enbrel) (2 trials)
etoposide (vepesid) (3 trials)
fam-trastuzumab deruxtecan-nxki (Enhertu) (33 trials)
fludarabine (fludara) (3 trials)
fluorouracil (efudex) (5 trials)
fondaparinux sodium (arixtra) (1 trial)
gemcitabine (gemzar) (5 trials)
idarubicin (idamycin) (5 trials)
iron dextran (Imferon) (3 trials)
laninamivir octanoate hydrate (1 trial)
mitoxantrone (novantrone) (1 trial)
omalizumab (xolair) (2 trials)
oseltamivir (tamiflu) (1 trial)
pemetrexed (alimta) (3 trials)
pertuzumab (perjeta) (3 trials)
pioglitazone (actos) (7 trials)
pregabalin (lyrica) (6 trials)
ramucirumab (cyramza) (1 trial)
sargramostim (leukine) (2 trials)
trastuzumab (herceptin) (8 trials)
trastuzumab emtansine (kadcyla) (2 trials)
Key: Daiichi Sankyo (31) Acquired (14)
abiraterone (zytiga) (1 trial)
anastrozole (arimidex) (2 trials)
atrial natriuretic peptide (1 trial)
azacitidine (vidaza) (2 trials)
durvalumab (imfinzi) (6 trials)
Filgrastim (neupogen) (1 trial)
hydrocortisone (solu-cortef) (1 trial)
insulin glargine (toujeo) (1 trial)
Key: Daiichi Sankyo (56) Acquired (10)
bexarotene (targretin) (1 trial)
binimetinib (mektovi) (1 trial)
bupropion (wellbutrin) (1 trial)
fluticasone (cutivate) (1 trial)
fulvestrant (faslodex) (1 trial)
human factor ix complex (prothrombin complex concentrate) (Bebulin) (1 trial)
itraconazole (sporanox) (3 trials)
methylene blue (proveblue) (1 trial)
omeprazole (prilosec) (2 trials)
osimertinib (tagrisso) (2 trials)
Acute Coronary Syndrome (Phase 4)
Adenocarcinoma (Phase 2)
Albuminuria (Phase 3)
Anemia (Phase 4)
Anemia, Iron-Deficiency (Phase 4)
Anemia, Sickle Cell (Phase 3)
Aortic Valve Stenosis (Phase 4)
Arteriosclerosis (Phase 3)
Arthritis (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Asthma (Phase 3)
Atherosclerosis (Phase 4)
Atrial Fibrillation (Phase 4)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Body Weight (Phase 1)
Bone Diseases (Phase 3)
Bone Marrow Diseases (Phase 3)
Bone Neoplasms (Phase 3)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Cachexia (Phase 2)
Calciphylaxis (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 1)
Cardiomyopathies (Phase 2)
Cardiovascular Diseases (Phase 4)
Carotid Artery Diseases (Phase 4)
Central Nervous System Neoplasms (Phase 1)
Cerebral Infarction (Phase 2)
Cholangiocarcinoma (Phase 2)
Chronic Disease (Phase 2)
Colorectal Neoplasms (Phase 3)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Coronary Restenosis (Phase 4)
Coronary Stenosis (Phase 4)
Coronavirus Infections (Phase 3)
Deficiency Diseases (Phase 4)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Desmoplastic Small Round Cell Tumor (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Nephropathies (Phase 3)
Diabetic Neuropathies (Phase 3)
Digestive System Neoplasms (Phase 2)
Dyslipidemias (Phase 4)
Eczema (Phase 2)
Embolism (Phase 4)
Embolism and Thrombosis (Phase 2)
Endometrial Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 2)
Essential Hypertension (Phase 4)
Fallopian Tube Neoplasms (Phase 2)
Fatty Liver (Phase 2)
Fibromyalgia (Phase 3)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Gastrointestinal Stromal Tumors (Phase 2)
Giant Cell Tumor of Tendon Sheath (Phase 4)
Giant Cell Tumors (Phase 4)
Glioma (Phase 2)
Glomerulonephritis (Phase 2)
Glucose Intolerance (Phase 3)
Head and Neck Neoplasms (Phase 3)
Heart Diseases (Phase 3)
Heart Failure (Phase 4)
Heart Failure, Systolic (Phase 4)
Hemorrhage (Phase 3)
Hip Fractures (Phase 3)
Hypercholesterolemia (Phase 4)
Hyperlipidemia, Familial Combined (Phase 4)
Hyperlipidemias (Phase 4)
Hyperlipoproteinemias (Phase 4)
Hyperlipoproteinemia Type II (Phase 3)
Hyperphosphatemia (Phase 1)
Hypertension (Phase 4)
Hypophosphatemia (Phase 2)
Infarction (Phase 3)
Infections (Phase 3)
Inflammatory Bowel Diseases (Phase 4)
Influenza, Human (Phase 3)
Insulin Resistance (Phase 4)
Intestinal Diseases (Phase 4)
Ischemia (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 3)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Lymphoid (Phase 1)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, T-Cell (Phase 2)
Liposarcoma (Phase 2)
Liposarcoma, Myxoid (Phase 2)
Liver Diseases (Phase 1)
Liver Neoplasms (Phase 2)
Lung Diseases (Phase 2)
Lung Diseases, Obstructive (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 2)
Macular Degeneration (Phase 1)
Macular Edema (Phase 1)
Melanoma (Phase 2)
Metabolic Syndrome (Phase 4)
Methemoglobinemia (Phase 1)
Migraine Disorders (Phase 4)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 1)
Muscular Dystrophies (Phase 2)
Muscular Dystrophy, Duchenne (Phase 2)
Myelodysplastic Syndromes (Phase 1)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 4)
Myofascial Pain Syndromes (Phase 3)
Neoplasm Metastasis (Phase 4)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Second Primary (Phase 3)
Nervous System Neoplasms (Phase 1)
Neuralgia (Phase 3)
Neuralgia, Postherpetic (Phase 3)
Neuroectodermal Tumors (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Non-ST Elevated Myocardial Infarction (Phase 3)
Osteoarthritis (Phase 3)
Osteoarthritis, Hip (Phase 3)
Osteoporosis (Phase 3)
Otitis (Phase 3)
Otitis Media (Phase 3)
Ovarian Neoplasms (Phase 2)
Overweight (Phase 4)
Pain, Postoperative (Phase 2)
Pancreatic Neoplasms (Phase 3)
Parkinson Disease (Phase 2)
Peripheral Arterial Disease (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Peripheral Vascular Diseases (Phase 2)
Prediabetic State (Phase 4)
Preleukemia (Phase 1)
Primary Myelofibrosis (Phase 1)
Prostatic Neoplasms (Phase 2)
Proteinuria (Phase 3)
Psoriasis (Phase 3)
Psychomotor Agitation (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Pulmonary Embolism (Phase 4)
Renal Insufficiency (Phase 3)
Renal Insufficiency, Chronic (Phase 4)
Restless Legs Syndrome (Phase 3)
Rhabdomyosarcoma (Phase 2)
Rhinitis (Phase 1)
Rhinitis, Allergic (Phase 1)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Sclerosis (Phase 1)
Seminoma (Phase 2)
Severe Acute Respiratory Syndrome (Phase 3)
Spinal Cord Injuries (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Stomach Neoplasms (Phase 3)
Stroke (Phase 2)
Syndrome (Phase 4)
Synovitis (Phase 3)
Synovitis, Pigmented Villonodular (Phase 3)
Thromboembolism (Phase 4)
Thrombosis (Phase 4)
Thyroid Carcinoma, Anaplastic (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Uterine Hemorrhage (Phase 3)
Vascular Diseases (Phase 4)
Venous Thromboembolism (Phase 4)
Venous Thrombosis (Phase 4)
Ventricular Dysfunction (Phase 2)
Ventricular Dysfunction, Left (Phase 2)
Wasting Syndrome (Phase 2)
Wet Macular Degeneration (Phase 1)
Wounds and Injuries (Phase 3)